Brooks Laboratories Limited (Brooks Laboratories) is a pharmaceutical contract research and manufacturing services company. It provides range of products catering to critical care segment in Parental Section such as Beta Lactam Cephalosporin and General Dry powder Injectables Ampoules and Liquid vials and Dry Syrups and Tablets. As of March 31 2010 its product portfolio consist of 26 dry powder injections 31 liquid injections five tablets and two dry syrups. It manufactures a range of products on third party basis for companies such as Zydus Cadila Alembic Intas Wockhardt Medley Biochem JB Chemical PDPL and Sanat. Brooks Laboratories has a range of products catering to critical care segment in parental section such as Beta Lactum Cephalosporin Carbapenems General Dry powder Injectables and Liquid Injectables. Its Carbapenems products include Inj Ertapenem and Inj Meropenem. Its Liquid Injectables include Inj Nandrolone Decanoate Inj Aceclofenac and Inj Midazolam.
Grow your wealth with more research recommendations
No Announcements
